Nautilus Biotechnology

📍 San Carlos, United States🗓 Founded 2016👥 175 employees💰 Last funded Jul 2017
Biotechnology Research🌐 nautilus.bio
Website LinkedIn
Born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, Nautilus (Nasdaq: NAUT) set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. The extraordinary team at Nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Nautilus Biotechnology?
Nautilus Biotechnology has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Nautilus Biotechnology last raise funding?
The most recent investment in Nautilus Biotechnology recorded on gritt.io was in July 2017.
When was Nautilus Biotechnology founded?
Nautilus Biotechnology was founded in 2016.
What industry is Nautilus Biotechnology in?
Nautilus Biotechnology operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Nautilus Biotechnology based?
Nautilus Biotechnology is headquartered in San Carlos, United States.